Stephanie Shepardson, Yvonne Riley, and Aimee Cole will join thousands in the iconic 37th Annual Jimmy Fund Walk presented by Hyundai. They’ll walk for Dana-Farber Cancer Institute to support research and care for all forms of cancer.

Hopkinton, MA—12 residents from Hopkinton will participate in the 2025 Jimmy Fund Walk presented by Hyundai on Sunday, October 5.

Aimee Cole, Nitya Jain, Margaret Rajkovich, Aleksandra Stipanovich, Jacqueline Zeigler, Josie Zeigler, Sue Wheeler, David Wheeler, Christian Wheeler, Andrea Wilk, and two other Hopkinton residents, along with thousands of other walkers, will participate in the iconic annual event that will unite the community to raise funds to support all forms of adult and pediatric care and research at Dana-Farber Cancer Institute.

The Jimmy Fund Walk aims to raise $9.5 million this year in the effort to prevent, treat, and defeat cancer.

For 36 years, the Jimmy Fund Walk has been a cornerstone of support for lifesaving cancer research and patient care at Dana-Farber,” said Caitlin Fink, vice president of The Jimmy Fund. “Every participant contributes directly to advancing lifesaving research and critically important cancer care.” Walk Day is more than just an event—it’s a celebration of hope and the shared commitment of the Jimmy Fund community.

One Walk, Four Distances, For All Cancers

The Jimmy Fund Walk takes place along the famed Boston Marathon^® course, and participants have the flexibility to choose from four distance options: 5K walk (from Dana-Farber’s Longwood Medical Campus); 10K walk (from Newton); Half Marathon walk (from Wellesley); and Marathon walk (from Hopkinton). Walkers who prefer to participate virtually can complete their chosen distance from any location.

Whatever route participants choose, they will be supported by hundreds of volunteers and treated to refueling stations with refreshments throughout the course. Walkers will be motivated by poster-sized photographs of Walk Heroes that appear along the course as inspiration.

All routes will conclude at the Jimmy Fund Walk Finish Line, Powered by Schneider Electric, located at Boston Common, near the corner of Charles and Beacon Street. Finish line activities will include a celebration with food, entertainment, and more.

Want to register for the Walk (#JimmyFundWalk) or support a walker?

Visit www.JimmyFundWalk.org or call 866-531-9255. Registrants can enter the promo code NEWS for $5 off the registration fee. All registered walkers will receive a bib, medal, and a Jimmy Fund Walk T-shirt. You can also sign up to volunteer on Walk Day.

About the Jimmy Fund

The Jimmy Fund, established in Boston in 1948, comprises community-based fundraising events and other programs that directly benefit Dana-Farber Cancer Institute’s lifesaving mission to provide compassionate patient care and groundbreaking cancer research for children and adults.

The Jimmy Fund is an official charity of the Boston Red Sox, the Massachusetts Chiefs of Police Association, the Pan-Mass Challenge, and the Variety Children’s Charity of New England. Since 1948, the generosity of millions of people has helped Dana-Farber save countless lives and alleviate the burden of cancer for patients and their families worldwide.

Follow the Jimmy Fund on Facebook, X, and Instagram:@TheJimmyFund. 

About Dana-Farber Cancer Institute 

Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment. Dana-Farber’s mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. Dana-Farber is a federally designated Comprehensive Cancer Center and a teaching affiliate of Harvard Medical School.   

Dana-Farber provides the latest treatments for adults with cancer through the Dana-Farber Brigham Cancer Center and for children through the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dana-Farber is the only hospital nationwide to hold a top 5 U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care.  

As a global leader in oncology, Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world, offering more than 1,100 clinical trials.